Hyperparathyroidism in men – morbidity and mortality during 21 years’ follow-up

References

• Palmer M, Jakobsson S, Akerstrom G, et al. Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest. 1988;18:39–46.
   PubMed Web of Science ®Google Scholar
• Lundgren E, Rastad J, Thurfjell E, et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery. 1997;121(3):287–294.
   PubMed Web of Science ®Google Scholar
• Buizert PJ, van Schoor NM, Simsek S, et al. PTH: a new target in arteriosclerosis? J Clin Endocrinol Metab. 2013;98(10):E1583–90.
   PubMed Web of Science ®Google Scholar
• Clifton-Bligh PB, Nery ML, Supramaniam R, et al. Mortality associated with primary hyperparathyroidism. Bone. 2015;74:121–124.
   PubMed Web of Science ®Google Scholar
• Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364–1367.
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Khan AA, Potts JT. Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–339.
   PubMed Web of Science ®Google Scholar
• Kontogeorgos G, Trimpou P, Laine CM, et al. Normocalcaemic, vitamin D-sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: a long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden. Clin Endocrinol. 2015;83(2):277–284.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Eriksson H, Hansson PO, et al. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med. 2009;266(3):268–276.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Rosengren A, Fu M, et al. Secular changes in cardiovascular risk factors in Swedish 50-year-old men over a 50-year period: the study of men born in 1913, 1923, 1933, 1943, 1953 and 1963. Eur J Prev Cardiolog. 2017;24(6):612–620.
   PubMed Web of Science ®Google Scholar
• Hagstrom E, Ahlstrom T, Arnlov J, et al. Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort. Atherosclerosis. 2015;238:420–426.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
   PubMed Web of Science ®Google Scholar
• Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–58.
   PubMed Web of Science ®Google Scholar
• Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int. 1995;56(2):104–108.
   PubMed Web of Science ®Google Scholar
• Hagstrom E, Ingelsson E, Sundstrom J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail. 2010;12:1186–1192.
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Rosen T, Mollerup CL, et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94(7):2255–2261.
   PubMed Web of Science ®Google Scholar
• Lundstam K, Heck A, Mollerup C, et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2015;100(4):1359–1367.
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Schalin-Jantti C, Rejnmark L, et al. Management of endocrine disease: unmet therapeutic, educational and scientific needs in parathyroid disorders. Eur J Endocrinol. 2019;181:1–19.
   PubMed Web of Science ®Google Scholar
• Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92(8):3001–3005.
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metab.. 2010;54(2):106–109.
   PubMedGoogle Scholar
• Cusano NE, Maalouf NM, Wang PY, et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab. 2013;98(7):2734–2741.
   PubMed Web of Science ®Google Scholar
• Khan AA, Hanley DA, Rizzoli R, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1–19.
   PubMed Web of Science ®Google Scholar
• Farrell CL, Nguyen L, Carter AC. Parathyroid hormone: data mining for age-related reference intervals in adults. Clin Endocrinol. 2018;88(2):311–317.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
   PubMed Web of Science ®Google Scholar
• Vignali E, Cetani F, Chiavistelli S, et al. Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy. Endocr Connect. 2015;4(3):172–178.
   PubMed Web of Science ®Google Scholar
• Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med. 2019;285(2):149–164.
   PubMed Web of Science ®Google Scholar
• Landin-Wilhelmsen K, Wilhelmsen L, Wilske J, et al. Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Goteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr. 1995;49(6):400–407.
   PubMed Web of Science ®Google Scholar
• Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163(3):197–203.
   PubMed Web of Science ®Google Scholar
• Harald K, Salomaa V, Jousilahti P, et al. Non-participation and mortality in different socioeconomic groups: the FINRISK population surveys in 1972–92. J Epidemiol Commun Health. 2007;61(5):449–454.
   PubMed Web of Science ®Google Scholar
• Bandeira L, Bilezikian J. Primary hyperparathyroidism.2016; 5:pii:F1000 Faculty Rev-1.
   Google Scholar
• Inaba M, Nakatsuka K, Imanishi Y, et al. Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem. 2004;50(2):385–390.
   PubMed Web of Science ®Google Scholar
• Cavalier E, Carlisi A, Bekaert AC, et al. New insights on the stability of the parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clin Chim Acta. 2012;413(1-2):353–354.
   PubMed Web of Science ®Google Scholar
• Antoniucci DM, Black DM, Sellmeyer DE. Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. Clin Chem. 2005;51(1):258–261.
   PubMed Web of Science ®Google Scholar